Sonata Raises $7 Million in Seed Funding
Sonata, a New York City-based healthcare startup, announced on July 20, 2026, that it has raised $7 million in a seed funding round. This round was led by Lux Capital, BoxGroup, and Sunflower Capital. The startup aims to revolutionize healthcare by providing personalized care plans tailored to individual biology.
Company Overview
Sonata offers a comprehensive healthcare service that tests over 250 biomarkers, analyzes a person's entire genome, and assesses cellular age. By combining the expertise of real doctors with artificial intelligence, Sonata creates customized care plans designed to help individuals feel younger and healthier. The company was co-founded by David Deng, who serves as the Chief Technology Officer, and Sagan Schultz, who is the Chief Executive Officer.
"Our mission is to empower individuals with the knowledge and tools to optimize their health," said Sagan Schultz, CEO of Sonata.
Strategic Use of Funds
While specific details on how the funds will be used were not disclosed, it is likely that the investment will support Sonata's efforts in expanding its platform capabilities and enhancing its AI-driven healthcare solutions. The funding may also be directed towards scaling operations and potentially increasing the company's market presence.
Leadership and Vision
Co-founders David Deng and Sagan Schultz bring a wealth of experience to Sonata, combining expertise in technology and healthcare. Their leadership is integral to the company's goal of transforming the way healthcare is delivered, making it more personalized and data-driven.
Looking Ahead
With this seed funding, Sonata is well-positioned to advance its mission of providing personalized healthcare solutions. The backing from prominent investors like Lux Capital, BoxGroup, and Sunflower Capital underscores the confidence in Sonata's innovative approach to healthcare.
The startup's focus on individualized care plans marks a significant shift from traditional healthcare models, emphasizing the potential for technology and personalized data to improve health outcomes.